Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Weder

Showing results (291-300 of 336) with videos related to

Pageof 34
Sort By:
The Lancet. Oncology|November 2, 2011
The MARS feasibility trial: conclusions not supported by dataWalter Weder, Rolf A Stahel, Paul Baas, et al.
Lung Cancer (Amsterdam, Netherlands)|April 12, 2011
Frequency and clinicopathologic correlates of KRAS amplification in non-small cell lung carcinomaPatrick L Wagner, Ann-Cathrin Stiedl, Theresia Wilbertz, et al.
British Journal of Cancer|April 17, 2019
Preoperative chemotherapy and radiotherapy concomitant to cetuximab in resectable stage IIIB NSCLC: a multicentre phase 2 trial (SAKK 16/08)Alessandra Curioni-Fontecedro, Jean Yannis Perentes, Hans Gelpke, et al.
Acta Oncologica (Stockholm, Sweden)|March 8, 2018
Influence of inter-observer delineation variability on radiomics stability in different tumor sitesMatea Pavic, Marta Bogowicz, Xaver Würms, et al.
Cancer Letters|May 28, 2017
The inhibitor of differentiation-1 (Id1) enables lung cancer liver colonization through activation of an EMT program in tumor cells and establishment of the pre-metastatic nicheEduardo Castañón, Alex Soltermann, Inés López, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 15, 2014
PI3K/mTOR signaling in mesothelioma patients treated with induction chemotherapy followed by extrapleural pneumonectomyByron K Y Bitanihirwe, Mayura Meerang, Martina Friess, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|April 2, 2016
Comparison of outcomes between neuroendocrine thymic tumours and other subtypes of thymic carcinomas: a joint analysis of the European Society of Thoracic Surgeons and the International Thymic Malignancy Interest GroupPier Luigi Filosso, Xiaopan Yao, Enrico Ruffini, et al.
Anesthesiology|May 7, 2009
Anesthetic-induced improvement of the inflammatory response to one-lung ventilationElisena De Conno, Marc P Steurer, Moritz Wittlinger, et al.
Lung Cancer (Amsterdam, Netherlands)|October 14, 2019
Perioperative course and quality of life in a prospective randomized multicenter phase III trial, comparing standard lobectomy versus anatomical segmentectomy in patients with non-small cell lung cancer up to 2 cm, stage IA (7th edition of TNM staging system)Georgios Stamatis, Gunda Leschber, Birte Schwarz, et al.
Neoplasia (New York, N.Y.)|March 6, 2008
EML4-ALK fusion lung cancer: a rare acquired eventSven Perner, Patrick L Wagner, Francesca Demichelis, et al.
Pageof 34

Showing results (291-300 of 336) with videos related to

Sort By:
Pageof 34
The Lancet. Oncology|November 2, 2011
The MARS feasibility trial: conclusions not supported by dataWalter Weder, Rolf A Stahel, Paul Baas, et al.
Lung Cancer (Amsterdam, Netherlands)|April 12, 2011
Frequency and clinicopathologic correlates of KRAS amplification in non-small cell lung carcinomaPatrick L Wagner, Ann-Cathrin Stiedl, Theresia Wilbertz, et al.
British Journal of Cancer|April 17, 2019
Preoperative chemotherapy and radiotherapy concomitant to cetuximab in resectable stage IIIB NSCLC: a multicentre phase 2 trial (SAKK 16/08)Alessandra Curioni-Fontecedro, Jean Yannis Perentes, Hans Gelpke, et al.
Acta Oncologica (Stockholm, Sweden)|March 8, 2018
Influence of inter-observer delineation variability on radiomics stability in different tumor sitesMatea Pavic, Marta Bogowicz, Xaver Würms, et al.
Cancer Letters|May 28, 2017
The inhibitor of differentiation-1 (Id1) enables lung cancer liver colonization through activation of an EMT program in tumor cells and establishment of the pre-metastatic nicheEduardo Castañón, Alex Soltermann, Inés López, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 15, 2014
PI3K/mTOR signaling in mesothelioma patients treated with induction chemotherapy followed by extrapleural pneumonectomyByron K Y Bitanihirwe, Mayura Meerang, Martina Friess, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|April 2, 2016
Comparison of outcomes between neuroendocrine thymic tumours and other subtypes of thymic carcinomas: a joint analysis of the European Society of Thoracic Surgeons and the International Thymic Malignancy Interest GroupPier Luigi Filosso, Xiaopan Yao, Enrico Ruffini, et al.
Anesthesiology|May 7, 2009
Anesthetic-induced improvement of the inflammatory response to one-lung ventilationElisena De Conno, Marc P Steurer, Moritz Wittlinger, et al.
Lung Cancer (Amsterdam, Netherlands)|October 14, 2019
Perioperative course and quality of life in a prospective randomized multicenter phase III trial, comparing standard lobectomy versus anatomical segmentectomy in patients with non-small cell lung cancer up to 2 cm, stage IA (7th edition of TNM staging system)Georgios Stamatis, Gunda Leschber, Birte Schwarz, et al.
Neoplasia (New York, N.Y.)|March 6, 2008
EML4-ALK fusion lung cancer: a rare acquired eventSven Perner, Patrick L Wagner, Francesca Demichelis, et al.
Pageof 34